Re: Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

被引：10
|
作者：
Nielsen, Torsten O.
Cheang, Maggie C. U.
Chia, Stephen K.
Voduc, David
Gao, Dongxia
Leung, Samuel
Bernard, Philip S.
Perou, Charles M.
Ellis, Matthew J.
机构：
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2009年 / 101卷 / 24期
关键词：
ESTROGEN-RECEPTOR;
D O I：
10.1093/jnci/djp390
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1730 / 1730
页数：1
相关论文
共 50 条
  • [1] Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
    Cheang, Maggie C. U.
    Chia, Stephen K.
    Voduc, David
    Gao, Dongxia
    Leung, Samuel
    Snider, Jacqueline
    Watson, Mark
    Davies, Sherri
    Bernard, Philip S.
    Parker, Joel S.
    Perou, Charles M.
    Ellis, Matthew J.
    Nielsen, Torsten O.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (10): : 736 - 750
  • [2] Progesterone receptor status and Ki-67 index may predict early relapse in luminal B/HER2 negative breast cancer patients
    Zong, Y.
    Zhu, L.
    Wu, J.
    Chen, X.
    Huang, O.
    Fei, X.
    He, J.
    Chen, W.
    Li, Y.
    Shen, K.
    CANCER RESEARCH, 2013, 73
  • [3] Progesterone receptor status and Ki-67 index provide prognostic value for early relapse in luminal B/HER2 negative breast cancer patients
    Zong, Y.
    Zhu, L.
    Wu, J.
    Chen, X.
    Huang, O.
    Fei, X.
    He, J.
    Chen, W.
    Li, Y.
    Shen, K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S445 - S445
  • [4] The Ki67 Index as a Prognostic Marker in Primary Hormone Receptor Positive/Her2 Negative Luminal Breast Carcinoma
    El-Gendi, Saba
    Talaat, Iman
    Abu-Sheasha, Ghada
    LABORATORY INVESTIGATION, 2017, 97 : 40A - 41A
  • [5] Ki67 Proliferative Index as an Invaluable Biomarker in Hormone Receptor (HR)-Positive Breast Cancer: Ki67 Labelling Index Can Reflect the Differences between Luminal A and B Subtypes Better Than HER2 Expression
    Park, Y. H.
    Ok, O-N
    Seo, J. J.
    Cho, E. Y.
    Lee, J. E.
    Nam, S. J.
    Yang, J. H.
    Ahn, J. S.
    Im, Y-H.
    CANCER RESEARCH, 2010, 70
  • [6] Progesterone Receptor Status and Ki-67 Index May Predict Early Relapse in Luminal B/HER2 Negative Breast Cancer Patients: A Retrospective Study
    Zong, Yu
    Zhu, Li
    Wu, Jiayi
    Chen, Xiaosong
    Huang, Ou
    Fei, Xiaochun
    He, Jianrong
    Chen, Weiguo
    Li, Yafen
    Shen, Kunwei
    PLOS ONE, 2014, 9 (08):
  • [7] Combined Detection of HER2, Ki67, and GSTP1 Genes on the Diagnosis and Prognosis of Breast Cancer
    Song, Bo
    Wang, Lu
    Zhang, Yang
    Li, Ning
    Dai, Hao
    Xu, Huafang
    Cai, Haifeng
    Yan, Jinyin
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (02) : 85 - 90
  • [8] The Correlation of Nottingham Prognostic Index with Immunoexpression of ER, PR, HER2, and Ki67 in Breast Cancer Tissue
    Ruangpratheep, Chetana
    Piyaisrakul, Supakorn
    ANNALS OF ONCOLOGY, 2019, 30 : 93 - 93
  • [9] Comprehensive Evaluation of Ki67 in Luminal/HER2-Negative Breast Cancer in the AMBER Consortium
    Khoury, Thaer
    Zirpoli, Gary
    Cohen, Stephanie M.
    Merzianu, Mihai
    Troester, Melissa
    Geradts, Joseph
    Worral, Amber
    Bshara, Wiam
    Ambrosone, Christine
    MODERN PATHOLOGY, 2016, 29 : 50A - 50A
  • [10] Comprehensive Evaluation of Ki67 in Luminal/HER2-Negative Breast Cancer in the AMBER Consortium
    Khoury, Thaer
    Zirpoli, Gary
    Cohen, Stephanie M.
    Merzianu, Mihai
    Troester, Melissa
    Geradts, Joseph
    Worral, Amber
    Bshara, Wiam
    Ambrosone, Christine
    LABORATORY INVESTIGATION, 2016, 96 : 50A - 50A
12345